Shenzhen Neptunus Bioengineering plans to raise CNY1bn ($150.69m) through the private placement of debt financing instruments.

The Chinese biochemical pharmaceuticals company plans to use the funds towards gold operations and repayment of debt.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Indian pharmaceutical company Denis Chem Lab plans to issue 21 million shares of its common stock priced at Rs84 ($1.31) a share to raise Rs179.32m ($2.8m).

Chinese healthcare solutions provider Humanwell Healthcare (Group) plans to dispose its bio-pharma unit for CNY350m ($53.01m).

Pharmaceutical Technology Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Pharmaceutical Technology Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now